Galmed Pharmaceuticals Ltd. (EOCN) vs GeoVax Labs Inc. (GOVX)

Galmed Pharmaceuticals Ltd. and GeoVax Labs Inc. are both Biotechnology companies. Galmed Pharmaceuticals Ltd. and GeoVax Labs Inc. are of similar size ($3.8M and $3.7M). GeoVax Labs Inc. grew revenue faster over the last twelve months: 963.6% against 87.8%. Across the 14 metrics below, Galmed Pharmaceuticals Ltd. leads on 7 and GeoVax Labs Inc. on 7.

Valuation

Metric EOCN GOVX Biotechnology median
P/E n/m n/m 7.88
P/S 1.70 0.26 11.47
P/B 0.27 0.91 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.54 0.07 0.74
EV/Sales (2.66) (0.22) 10.73
Earnings yield (418.18%) (1,715.69%) (28.84%)
Free cash flow yield (247.30%) (1,151.45%) (23.03%)

Profitability

Metric EOCN GOVX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.21%) (891.59%) (57.72%)
Return on assets (55.03%) (408.79%) (49.22%)
Return on invested capital (163.19%) 0.00% 0.00%

Growth

Metric EOCN GOVX Biotechnology median
Revenue growth (TTM) 87.83% 963.56% 5.64%
EPS growth (last fiscal year) 70.42% 81.41% —
Revenue growth, 5-year CAGR — 16.18% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EOCN GOVX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.16 1.54 4.73
Net debt to EBITDA 1.31 0.14 0.96

Dividend

Metric EOCN GOVX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EOCN GOVX Biotechnology median
Market cap 3.77m 3.67m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack